{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:25:04Z","timestamp":1790979904128,"version":"4.1.0"},"reference-count":19,"publisher":"Microbiology Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,7,1]]},"DOI":"10.1099\/vir.0.18996-0","type":"journal-article","created":{"date-parts":[[2003,6,16]],"date-time":"2003-06-16T23:29:24Z","timestamp":1055806164000},"page":"1921-1925","source":"Crossref","is-referenced-by-count":80,"title":["Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity"],"prefix":"10.1099","volume":"84","author":[{"given":"A.","family":"Bellon","sequence":"first","affiliation":[{"name":"Virology, Aventis Behring GmbH, PO Box 1230, 35002 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Seyfert-Brandt","sequence":"additional","affiliation":[{"name":"Virology, Aventis Behring GmbH, PO Box 1230, 35002 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Lang","sequence":"additional","affiliation":[{"name":"Virology, Aventis Behring GmbH, PO Box 1230, 35002 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Baron","sequence":"additional","affiliation":[{"name":"Industry and Health Policy, Aventis Behring SA, 46 Quai de la Rap\u00e9e, 75601 Paris Cedex 12, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gr\u00f6ner","sequence":"additional","affiliation":[{"name":"Virology, Aventis Behring GmbH, PO Box 1230, 35002 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vey","sequence":"additional","affiliation":[{"name":"Virology, Aventis Behring GmbH, PO Box 1230, 35002 Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"345","reference":[{"key":"R1","first-page":"187","article-title":"Prion diseases","volume-title":"In Biological Safety \u2013 Principles and Practices","author":"Baron","year":"2000"},{"key":"R2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0003-9861(87)90380-8","article-title":"Isolation and structural studies of the intact scrapie agent protein","volume":"258","author":"Bolton","year":"1987","journal-title":"Arch Biochem Biophys"},{"key":"R3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ana.410350504","article-title":"Human spongiform encephalopathy: the National Institutes of Health series of 300\u2005cases of experimentally transmitted disease","volume":"35","author":"Brown","year":"1994","journal-title":"Ann Neurol"},{"key":"R4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1537-2995.1998.38998408999.x","article-title":"The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy","volume":"38","author":"Brown","year":"1998","journal-title":"Transfusion"},{"key":"R5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1067\/mlc.2001.111951","article-title":"Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt\u2013Jakob disease","volume":"137","author":"Brown","year":"2001","journal-title":"J Lab Clin Med"},{"key":"R6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(01)05411-3","article-title":"Detection of variant Creutzfeldt\u2013Jakob disease infectivity in extraneural tissues","volume":"358","author":"Bruce","year":"2001","journal-title":"Lancet"},{"key":"R7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1246-7820(01)00130-6","article-title":"The safety of human blood: experimental TSE\/prion infectivity studies","volume":"8","author":"Cervenakova","year":"2001","journal-title":"Transfus Clin Biol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(97)24002-X","article-title":"Diagnosis of new variant Creutzfeldt\u2013Jakob disease by tonsil biopsy","volume":"349","author":"Hill","year":"1997","journal-title":"Lancet"},{"key":"R9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(00)02719-7","article-title":"Transmission of BSE by blood transfusion in sheep","volume":"356","author":"Houston","year":"2000","journal-title":"Lancet"},{"key":"R10","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1099\/0022-1317-83-11-2897","article-title":"Transmission of prion diseases by blood transfusion","volume":"83","author":"Hunter","year":"2002","journal-title":"J Gen Virol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/jmbi.2000.3986","article-title":"Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus","volume":"301","author":"Li","year":"2000","journal-title":"J Mol Biol"},{"key":"R12","article-title":"Working group on international reference materials for diagnosis and study of transmissible spongiform encephalopathies (TSEs): second meeting","author":"Minor","year":"2000"},{"key":"R13","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-08843-2","volume-title":"Monoklonale Antik\u00f6rper: Herstellung und Charakterisierung","author":"Peters","year":"1985"},{"key":"R14","article-title":"Conformation-dependent immunoassays: an update. Abstract of presentation given at Cambridge Healthtech Institute's Ninth Annual Transmissible Spongiform Encephalopathies Conference , 12\u201313 February 2003","author":"Safar","year":"2003"},{"key":"R15","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/2654","article-title":"Eight prion strains have PrP(Sc) molecules with different conformations","volume":"4","author":"Safar","year":"1998","journal-title":"Nat Med"},{"key":"R16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nbt748","article-title":"Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice","volume":"20","author":"Safar","year":"2002","journal-title":"Nat Biotechnol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"31479","DOI":"10.1074\/jbc.C100278200","article-title":"A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases","volume":"276","author":"Shaked","year":"2001","journal-title":"J Biol Chem"},{"key":"R18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/biol.2002.0327","article-title":"Purity of spiking agent affects partitioning of prions in plasma protein purification","volume":"30","author":"Vey","year":"2002","journal-title":"Biologicals"},{"key":"R19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","article-title":"Tissue distribution of protease resistant prion protein in variant Creutzfeldt\u2013Jakob disease using a highly sensitive immunoblotting assay","volume":"358","author":"Wadsworth","year":"2001","journal-title":"Lancet"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.18996-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T15:24:06Z","timestamp":1582212246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.18996-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,1]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.18996-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,1]]}}}